New study finds GLP-1 meds like Ozempic may make food taste sweeter or saltier. Here's how this new side effect might impact ...

Tirzepatide offers more favorable return on investment, but greater benefits seen at lower costs for Roux-en-Y gastric bypass ...

Weight loss drug treatment has relatively low adherence. Despite experts advocating for lifelong adherence, more than half of ...

Omada Health (OMDA) remains a buy, driven by accelerating membership growth, multi-condition adoption, and a massive ...

Novo Nordisk › Novo Nordisk's (NYSE: NVO) leading medications have been hot discussion topics for years. Many Americans might ...

It’s time for a fun family challenge! Watch as we play the match game to see who’s got the best intuition—can anyone beat the ...